In last trading session, Jaguar Health Inc (NASDAQ:JAGX) saw 0.53 million shares changing hands with its beta currently measuring 0.88. Company’s recent per share price level of $0.93 trading at $0.06 or 6.00% at ring of the bell on the day assigns it a market valuation of $10.92M. That closing price of JAGX’s stock is at a discount of -2222.58% from its 52-week high price of $21.60 and is indicating a premium of 9.68% from its 52-week low price of $0.84. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.82 million shares which gives us an average trading volume of 357.61K if we extend that period to 3-months.
For Jaguar Health Inc (JAGX), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 1 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 1 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.74 in the current quarter.
Jaguar Health Inc (NASDAQ:JAGX) trade information
Upright in the green during last session for gaining 6.00%, in the last five days JAGX remained trading in the red while hitting it’s week-highest on Monday, 12/16/24 when the stock touched $0.93 price level, adding 5.64% to its value on the day. Jaguar Health Inc’s shares saw a change of -89.81% in year-to-date performance and have moved -4.52% in past 5-day. Jaguar Health Inc (NASDAQ:JAGX) showed a performance of -5.55% in past 30-days. Number of shares sold short was 0.33 million shares which calculate 1.12 days to cover the short interests.
Jaguar Health Inc (JAGX) estimates and forecasts
Statistics highlight that Jaguar Health Inc is scoring comparatively higher than the scores of other players of the relevant industry. The company lost -75.58% of value to its shares in past 6 months, showing an annual growth rate of 99.26% while that of industry is 16.40. Apart from that, the company came raising its revenue forecast for fiscal year 2024.
1 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 3.13M for the same. And 1 analysts are in estimates of company making revenue of 3.29M in the next quarter.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 86.10% during past 5 years. In 2024, company’s earnings growth rate is likely to be around 99.26% while estimates for its earnings growth in next 5 years are of 40.00%.
Jaguar Health Inc (NASDAQ:JAGX)’s Major holders
Insiders are in possession of 12.02% of company’s total shares while institution are holding 1.96 percent of that, with stock having share float percentage of 2.22%. Investors also watch the number of corporate investors in a company very closely, which is 1.96% institutions for Jaguar Health Inc that are currently holding shares of the company.
